Soleno Therapeutics (SLNO) Retained Earnings (2013 - 2026)
Soleno Therapeutics (SLNO) posted quarterly Retained Earnings of -$1.8 million for Q1 2026, up 99.63% year-over-year from -$920705.8 in Q1 2025, and up 99.57% quarter-over-quarter from -$431.4 million in Q4 2025.
Soleno Therapeutics (SLNO) Retained Earnings (2013 - 2026) Analysis & Trends
Soleno Therapeutics (SLNO) has reported Retained Earnings for 14 consecutive years, with -$1.8 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Retained Earnings rose 99.63% year-over-year to -$1.8 million; the TTM figure through Mar 2026 stood at -$1.8 million (up 99.63% YoY), while the FY2025 annual figure was -$431.4 million, down 119593.07% from the prior year.
- Retained Earnings rose to -$1.8 million in Q1 2026 per SLNO's latest filing, from -$431.4 million in the prior quarter.
- Across five years, Retained Earnings topped out at $361000.0 in Q4 2024 and bottomed at -$496.0 million in Q1 2025.
- Historically, Retained Earnings has averaged -$243.6 million across 5 years, with a median of -$254.3 million in 2023.
- Annual changes were most pronounced in 2023 — Retained Earnings tumbled 13255600.0% — and 2024, when it jumped 100.13%.
- Soleno Therapeutics' Retained Earnings stood at -$237.4 million in 2022, then fell by 16.42% to -$276.4 million in 2023, then surged by 100.13% to $361000.0 in 2024, then slumped by 119593.07% to -$431.4 million in 2025, then soared by 99.57% to -$1.8 million in 2026.
- Business Quant data shows SLNO's Retained Earnings at -$1.8 million in Q1 2026, -$431.4 million in Q4 2025, and -$474.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 15.69 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 37.62 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -4.00 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 13.05 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -104.13 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 4.38 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -6.33 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 6.57 Bn |
| 10 | Soleno Therapeutics | 2.74 Bn | 2.49 Bn | 93.41 Mn | -1.84 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.84 Mn |
| Dec 31, 2025 | -431.37 Mn |
| Sep 30, 2025 | -474.73 Mn |
| Jun 30, 2025 | 85,000.00 |
| Mar 31, 2025 | -496.03 Mn |
| Dec 31, 2024 | 361,000.00 |
| Sep 30, 2024 | -396.28 Mn |
| Jun 30, 2024 | -319.66 Mn |
| Mar 31, 2024 | -297.81 Mn |
| Dec 31, 2023 | -276.41 Mn |
| Sep 30, 2023 | -265.11 Mn |
| Jun 30, 2023 | -254.30 Mn |
| Mar 31, 2023 | -245.78 Mn |
| Dec 31, 2022 | -237.42 Mn |
| Sep 30, 2022 | -2,000.00 |
| Jun 30, 2022 | -225.80 Mn |
| Mar 31, 2022 | -219.10 Mn |
| Dec 31, 2021 | -213.36 Mn |
| Sep 30, 2021 | -210.50 Mn |
| Jun 30, 2021 | -202.39 Mn |